As of 2024-12-15, the Relative Valuation of Forte Biosciences Inc (FBRX) is (524.64) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.15 USD, the upside of Forte Biosciences Inc based on Relative Valuation is -2366.2%.
The range of the Relative Valuation is (485.29) - (450.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (485.29) - (450.16) | (524.64) |
| Upside | -2196.3% - -2044.5% | -2366.2% |
| Date | P/E |
| 2024-12-13 | -0.99 |
| 2024-12-12 | -0.98 |
| 2024-12-11 | -1.02 |
| 2024-12-10 | -1.00 |
| 2024-12-09 | -1.09 |
| 2024-12-06 | -1.20 |
| 2024-12-05 | -1.05 |
| 2024-12-04 | -0.96 |
| 2024-12-03 | -1.02 |
| 2024-12-02 | -1.00 |
| 2024-11-29 | -0.93 |
| 2024-11-27 | -0.84 |
| 2024-11-26 | -0.71 |
| 2024-11-25 | -0.69 |
| 2024-11-22 | -0.68 |
| 2024-11-21 | -0.67 |
| 2024-11-20 | -0.58 |
| 2024-11-19 | -0.25 |
| 2024-11-18 | -0.26 |
| 2024-11-15 | -0.25 |
| 2024-11-14 | -0.24 |
| 2024-11-13 | -0.24 |
| 2024-11-12 | -0.24 |
| 2024-11-11 | -0.23 |
| 2024-11-08 | -0.22 |
| 2024-11-07 | -0.21 |
| 2024-11-06 | -0.20 |
| 2024-11-05 | -0.20 |
| 2024-11-04 | -0.19 |
| 2024-11-01 | -0.18 |
| 2024-10-31 | -0.19 |
| 2024-10-30 | -0.20 |
| 2024-10-29 | -0.20 |
| 2024-10-28 | -0.20 |
| 2024-10-25 | -0.20 |
| 2024-10-24 | -0.20 |
| 2024-10-23 | -0.21 |
| 2024-10-22 | -0.20 |
| 2024-10-21 | -0.20 |
| 2024-10-18 | -0.20 |
| 2024-10-17 | -0.19 |
| 2024-10-16 | -0.20 |
| 2024-10-15 | -0.20 |
| 2024-10-14 | -0.20 |
| 2024-10-11 | -0.19 |
| 2024-10-10 | -0.21 |
| 2024-10-09 | -0.21 |
| 2024-10-08 | -0.21 |
| 2024-10-07 | -0.21 |
| 2024-10-04 | -0.21 |